Get started
Author

Sheyda Houshmandfar

ORCID: 0000-0003-4200-2867
Observed ORCID: 0000-0003-4200-2867
OpenAlex ID: A5064242574
miRNA-223 as a regulator of inflammation and NLRP3 inflammasome, the main fragments in the puzzle of immunopathogenesis of different inflammatory diseases and COVID-19
2021 · Sheyda Houshmandfar, Ali Saeedi-Boroujeni, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 61
PDF
Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19
2021 · Ali Saeedi-Boroujeni, Mohammad-Reza Mahmoudian-Sani, et al. · Immunopharmacology and Immunotoxicology · 45
Interleukin‐22 and intestinal homeostasis: Protective or destructive?
2020 · Mojtaba Shohan, Razieh Dehghani, et al. · IUBMB Life · 39
PDF
Unraveling the immunometabolism puzzle: Deciphering systemic sclerosis pathogenesis
2024 · Maryam Masoumi, Ali Bayat Bodaghi, et al. · Heliyon · 7
Comparing the expression of MiR-223-NLRP3-IL-1β axis and serum IL-1β levels in patients with severe COVID-19 and healthy individuals
2023 · Sheyda Houshmandfar, Ali Khodadadi, et al. · Immunobiology · 7
Resveratrol; an inflammasome inhibitor and a potential therapy for severe cases of COVID-19
2021 · Mohammad-Reza Mahmoudian-Sani, Ali Saeedi Boroujeni, et al. · Immunopathologia Persa · 5
PDF
The genetic puzzle of rheumatoid arthritis: Causes, progression, and treatment
2025 · Maryam Masoumi, Mahdi Solaymani, et al. · Biochemistry and Biophysics Reports · 4
miRNAs: Key Molecules in the Immunopathogenesis of Betacoronaviruses
2024 · Mohammad Reza Mahmoudian-Sani, Sheyda Houshmandfar, et al. · Immunology and Genetics Journal · 1
Exosome in Hashimoto’s thyroiditis: from pathogenesis to diagnostic and therapeutic potential
2026 · Amirhossein Faghih Ojaroodi, Maryam Zamani Sani, et al. · Molecular Biology Reports
Works count: 9
Citation count: 169
H-index: 5
I10-index: 3
Year
Topic
Type